FDA Inspection
Thymoorgan Pharmazie GmbhThymoorgan Pharmazie Gmbh – FDA Inspection, May 22, 2014
Record Details
This FDA Inspection record concerns Thymoorgan Pharmazie Gmbh, with an inspection on May 22, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Thymoorgan Pharmazie Gmbh
- Inspection Date
- May 22, 2014
- Product Type
- Drugs
View Company Profile
ID · 399feebf-70c0-488e-be2c-a34465a28393
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 883211
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Thymoorgan Pharmazie Gmbh
7| Date | Classification | Office | Project area |
|---|---|---|---|
| April 25, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 6, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 20, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 23, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 16, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Thymoorgan Pharmazie Gmbh
- FDA Inspection 1203954 - 2023-04-25
- FDA Inspection 1207607 - 2022-10-06
- FDA Inspection 1123031 - 2019-06-20
- FDA Inspection 1053793 - 2018-04-23
- FDA Inspection 1003153 - 2016-12-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.